Koninklijke Philips (PHG) Cash & Current Investments (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Cash & Current Investments of $3.3 billion for Q2 2026, up 20.23% year-over-year from $2.8 billion in Q2 2025, and up 6.28% quarter-over-quarter from $3.1 billion in Q1 2026.
Koninklijke Philips (PHG) Cash & Current Investments (2009 - 2026) Analysis & Trends
Koninklijke Philips' Cash & Current Investments history runs 18 years deep, the most recent figure standing at $3.3 billion for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 20.23% year-over-year to $3.3 billion; the TTM figure through Jun 2026 stood at $3.3 billion (up 20.23% YoY), while the FY2025 annual figure was $3.3 billion, up 37.48% from the prior year.
- Cash & Current Investments for Q2 2026 stood at $3.3 billion, up from $3.1 billion in the prior quarter.
- The five-year high for Cash & Current Investments was $3.3 billion in Q4 2025, with the low at $1.2 billion in Q2 2023.
- The 5-year median for Cash & Current Investments is $2.0 billion (2023), against an average of $2.1 billion.
- The sharpest annual moves came in 2022 and 2026: Cash & Current Investments plunged 71.9% in 2022, then soared 143.49% in 2026.
- Koninklijke Philips' Cash & Current Investments stood at $1.2 billion in 2022, then surged by 66.88% to $2.0 billion in 2023, then soared by 31.47% to $2.6 billion in 2024, then increased by 26.38% to $3.3 billion in 2025, then decreased by 0.77% to $3.3 billion in 2026.
- Business Quant data shows PHG's Cash & Current Investments at $3.3 billion in Q2 2026, $3.1 billion in Q1 2026, and $3.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.43 Bn | 193.83 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 126.52 Bn | 123.04 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.76 Bn | 109.54 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 52.20 Bn | 47.95 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.75 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.09 Bn | 22.61 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Zimmer Biomet Holdings | 19.11 Bn | 18.70 Bn | 1.54 Bn | 410.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.32 Bn |
| Mar 31, 2026 | 3.12 Bn |
| Dec 31, 2025 | 3.35 Bn |
| Sep 30, 2025 | 2.33 Bn |
| Jun 30, 2025 | 2.76 Bn |
| Mar 31, 2025 | 1.28 Bn |
| Dec 31, 2024 | 2.65 Bn |
| Sep 30, 2024 | 1.89 Bn |
| Jun 30, 2024 | 1.95 Bn |
| Mar 31, 2024 | 1.99 Bn |
| Dec 31, 2023 | 2.01 Bn |
| Sep 30, 2023 | 1.26 Bn |
| Jun 30, 2023 | 1.17 Bn |
| Mar 31, 2023 | 1.26 Bn |
| Dec 31, 2022 | 1.21 Bn |
| Sep 30, 2022 | 1.27 Bn |
| Jun 30, 2022 | 2.40 Bn |
| Mar 31, 2022 | 2.58 Bn |
| Dec 31, 2021 | 2.64 Bn |
| Sep 30, 2021 | 4.51 Bn |